15
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Peripheral Blood Lymphocyte Surface Antigen Expression and Prognosis in Myeloma: Australian Leukaemia Study Group Study

, , , , , & show all
Pages 303-309 | Received 29 Oct 1993, Published online: 01 Jul 2009

References

  • MRC working party for therapeutic trials in leukaemia. Report on the first myelomatosis trial-analysis of presenting features of prognostic importance. Br. J. Haematol. 1973; 24: 123–139
  • Alexanian R., Balcerzak S., Bonnett J. D., et al. Prognostic factors in multiple myeloma. Cancer 1975; 36: 1192–1201
  • Durie B. G. M., Salmon S. E. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842–854
  • Woodruff R. K., Wads worth J, Malpas J. S., Tobias J. S. Clinical staging in multiple myeloma. Br. J. Haematol. 1979; 42: 199–205
  • Cooper D. A., Miller A. C., Penny R. Biosynthesis of immunoglobulin in human immunoproliferative diseases. II. Comparison of tumour cell mass in multiple myeloma measured by synthetic rate studies with that calculated from clinical staging systems. Acta. Haematol. 1982; 68: 224–236
  • Pennec Y., Mottier D., Youinou P., et al. Critical study of staging in multiple myeloma. Scand. J. Haematol. 1983; 30: 183–190
  • Joshua D. E. Biology of multiple myeloma-Host-tumour interactions and immune regulation of disease activity. Hematol. Oncol. 1988; 6: 83–88
  • Joshua D. E., Snowdon L., Gibson J., et al. Plateau phase revisited. Haematol. Rev. Commun. 1991; 5: 59–66
  • Greipp P. R., Katzmann J. A., O'Fallon W. M., Kyle R. A. Value of β2-microglobulin level and plasma cell labelling indices as prognostic factors in patients with newly diagnosed myeloma. Blood 1988; 72: 219–223
  • Brown R., Joshua D. E., Ioannidis R., Kronenberg H. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma. Aust. NZ J. Med. 1989; 19: 226–232
  • Chronic Leukaemia-Myeloma Task Force. Proposed guidelines for protocol studies II. Plasma Cell Myeloma. Cancer Chem. Rep. Part 3 1973; 4: 145–158
  • Wearne A., Joshua D. E., Kronenberg H. Monitoring myeloma: Light chain isotype suppression-a new parameter. Aust. NZ J. Med. 1985; 15: 629–633
  • Dixon W. J. BMDP Statistical Software Manual. Berkeley Press: University of California Press. 1990
  • Omede P., Boccadoro M., Gallone G., et al. Multiple myeloma: Increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 1990; 76: 1375–1379
  • Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 1990; 11: 443–449
  • Bataille R., Jourdan M., Zhang X.-G., Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyspasias. J. Clin. Invest. 1989; 84: 2008–2011
  • Ruiz-Arguelles G. J., Katzmann J. A., Greipp P. R., Gonchoroff N. J., Garton J. P., Kyle R. A. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood 1984; 64: 352–356
  • Chiu E. K. W., Ganeshaguru K., Hoffbrand A. V., Mehta A. B. Circulating monoclonal B lymphocytes in multiple myeloma. Br. J. Haematol. 1989; 72: 28–31
  • Boccadoro M., Omede P., Massaia M., et al. Human myeloma: Several subsets of circulating lymphocytes express plasma cell-associated antigens. Eur. J. Haematol. 1988; 40: 299–304
  • Warburton P., Petersen A., Nelson M., Gibson J., Joshua D. E. Immunophenotypic analysis of CD38 + peripheral blood lymphocytes in multiple myeloma. Aust. NZ J. Med. 1991; 21: 942
  • King M. A., Rodicchi M. A. Monitoring circulating B cells in patients with multiple myeloma at diagnosis or in plateau phase: How prevalent is light chain isotype suppression?. Br. J. Haematol. 1992; 81: 218–222
  • Letwin B. W., Wallace P. K., Muirhead K., Hensler G. L., Kashatus W. H., Horan P. K. An improved clonal excess assay using flow cytometry and B-cell gating. Blood 1990; 75: 1178–1185
  • Oritani K., Katagiri S., Tominaga N., et al. Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: Isotypic discordance and clonal B-cell excess. Br. J. Haematol. 1990; 75: 10–15
  • Buchi G., Girotto M., Veglio M., et al. Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labelling index in monoclonal gammopathies. Haematologica 1990; 75: 132–136
  • Pettersson D., Mellstedt H., Holm G. Monoclonal B lymphocytes in multiple myeloma. Stand. J. Immunol. 1980; 12: 375–382

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.